載入...

Bevacizumab for Glioblastoma—A Promising Drug or Not?

Two double blind, placebo-controlled, and randomized phase III studies were conducted, and the results including OS’s were reported at the ASCO Meeting in June 2013, which was the beginning of confusion surrounding this topic. This is a review article not only summarizing the previous evidence, but...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Nagane, Motoo, Nishikawa, Ryo
格式: Artigo
語言:Inglês
出版: MDPI 2013
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3875948/
https://ncbi.nlm.nih.gov/pubmed/24213559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers5041456
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!